Artículos por temáticas

Management of suspected Alzheimer's disease patients by specialist physicians at the first visit in Spain: First Consultation Study

Martínez Lozano MD, Guzmán Quilo C; Primeras Consultas Study Group.

Expert Rev Neurother. 2011 May;11(5):657-63. doi: 10.1586/ern.11.45.

Prognostic factors for a favourable long-term outcome from an integrative psychotherapeutic nursing home programme

Bakker TJ, Duivenvoorden HJ, van der Lee J, Olde Rikkert MG, Beekman AT, Ribbe MW.

Dement Geriatr Cogn Disord. 2011;32(5):318-31. doi: 10.1159/000334969. Epub 2012 Jan 25.

Recovery of hippocampal network connectivity correlates with cognitive improvement in mild Alzheimer's disease patients treated with donepezil assessed by resting-state fMRI

Goveas JS, Xie C, Ward BD, Wu Z, Li W, Franczak M, Jones JL, Antuono PG, Li SJ.

J Magn Reson Imaging. 2011 Oct;34(4):764-73. doi: 10.1002/jmri.22662. Epub 2011 Jul 18.

Activation of the α-secretase processing of AβPP as a therapeutic approach in Alzheimer's disease

Vincent B, Govitrapong P.

J Alzheimers Dis. 2011;24 Suppl 2:75-94. doi: 10.3233/JAD-2011-110218.

Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trial

Kamphuis PJ, Verhey FR, Olde Rikkert MG, Twisk JW, Swinkels SH, Scheltens P.

J Nutr Health Aging. 2011 Aug;15(8):720-4. doi: 10.1007/s12603-011-0105-6.

Docking of the alkaloid geissospermine into acetylcholinesterase: a natural scaffold targeting the treatment of Alzheimer's disease

Araújo JQ, Lima JA, Pinto Ada C, de Alencastro RB, Albuquerque MG.

J Mol Model. 2011 Jun;17(6):1401-12. doi: 10.1007/s00894-010-0841-2. Epub 2010 Sep 16.

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology

O'Brien JT, Burns A; BAP Dementia Consensus Group.

J Psychopharmacol. 2011 Aug;25(8):997-1019. doi: 10.1177/0269881110387547. Epub 2010 Nov 18.

Remembering relationships: preserved emotion-based learning in Alzheimer's disease

Evans-Roberts CE, Turnbull OH.

Exp Aging Res. 2011 Jan;37(1):1-16. doi: 10.1080/0361073X.2011.536750.

[Prescription differences of dementia drugs in urban and rural areas in Germany]

Bohlken J, Selke GW, van den Bussche H.

Psychiatr Prax. 2011 Jul;38(5):232-6. doi: 10.1055/s-0030-1266020. Epub 2011 Mar 21.

Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond

Decker M.

Curr Med Chem. 2011;18(10):1464-75. doi: 10.2174/092986711795328355.

Cellular protection and therapeutic potential of tocotrienols

Catalgol B, Batirel S, Ozer NK.

Curr Pharm Des. 2011;17(21):2215-20. doi: 10.2174/138161211796957436.

[Alzheimer: destiny of a disease]

Deleuze J.

Rev Prat. 2011 Sep;61(7):891.

Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study

Henderson ST, Poirier J.

BMC Med Genet. 2011 Oct 12;12:137. doi: 10.1186/1471-2350-12-137.

A comprehensive strategy for dementia from primary prevention to end-stage management

Arai H.

Psychogeriatrics. 2011 Sep;11(3):131-4. doi: 10.1111/j.1479-8301.2011.00379.x.

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease

Devanand DP, Pelton GH, Cunqueiro K, Sackeim HA, Marder K.

Int J Geriatr Psychiatry. 2011 Sep;26(9):937-43. doi: 10.1002/gps.2630. Epub 2010 Dec 28.